Your browser doesn't support javascript.
loading
Long-Term Outcome of Repetitive Transcranial Magnetic Stimulation in a Large Cohort of Patients With Cocaine-Use Disorder: An Observational Study.
Madeo, Graziella; Terraneo, Alberto; Cardullo, Stefano; Gómez Pérez, Luis J; Cellini, Nicola; Sarlo, Michela; Bonci, Antonello; Gallimberti, Luigi.
Afiliación
  • Madeo G; Novella Fronda Foundation, Padua, Italy.
  • Terraneo A; Novella Fronda Foundation, Padua, Italy.
  • Cardullo S; Novella Fronda Foundation, Padua, Italy.
  • Gómez Pérez LJ; Novella Fronda Foundation, Padua, Italy.
  • Cellini N; Department of General Psychology, University of Padua, Padua, Italy.
  • Sarlo M; Padova Neuroscience Center, University of Padua, Padua, Italy.
  • Bonci A; Department of General Psychology, University of Padua, Padua, Italy.
  • Gallimberti L; Padova Neuroscience Center, University of Padua, Padua, Italy.
Front Psychiatry ; 11: 158, 2020.
Article en En | MEDLINE | ID: mdl-32180745
ABSTRACT

Background:

Cocaine is a psychostimulant drug used as performance enhancer throughout history. The prolonged use of cocaine is associated with addiction and a broad range of cognitive deficits. Currently, there are no medications proven to be effective for cocaine-use disorder (CocUD). Previous preliminary clinical work suggests some benefit from repetitive transcranial magnetic stimulation (rTMS) stimulating the prefrontal cortex (PFC), involved in inhibitory cognitive control, decision-making and attention. All published studies to date have been limited by small sample sizes and short follow-up times.

Methods:

This is a retrospective observational study of 284 outpatients (of whom 268 were men) meeting DSM-5 criteria for CocUD. At treatment entry, most were using cocaine every day or several times per week. All patients underwent 3 months of rTMS and were followed for up to 2 years, 8 months. Self-report, reports by family or significant others and regular urine screens were used to assess drug use.

Results:

Median time to the first lapse (resumption of cocaine use) since the beginning of treatment was 91 days. For most patients, TMS was re-administered weekly, then monthly, throughout follow-up. The decrease in frequency of rTMS sessions was not accompanied by an increase in lapses to cocaine use. Mean frequency of cocaine use was <1·0 day/month (median 0), while serious rTMS-related adverse events were infrequent, consistent with published reports from smaller studies.

Conclusions:

This is the first follow-up study to show that rTMS treatment is accompanied by long-lasting reductions in cocaine use in a large cohort.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Psychiatry Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Psychiatry Año: 2020 Tipo del documento: Article País de afiliación: Italia